Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, October 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 14,552 followers.

@UsuarezMD @PabloArangoGuer De acuerdo! BUD y FLU biológicamente parecen no ser iguales (https://t.co/K4LFJ7N3wp) pero ambos aumentan el riesgo (https://t.co/uOqten3BKS); ahora la dosis posiblemente si es un tema a considerar (https://t.co/ogyn6NiMaY).

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD. https://t.co/wtRIhXFcEn

RT @SleepResearch_: Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD. ht…

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD. https://t.co/yN3owHzi5y

Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD https://t.co/tRYHIkdb2C